https://www.selleckchem.com/pr....oducts/ionomycin.htm
BACKGROUND Acute megakaryoblastic leukaemia (AMKL) is a subtype of myeloid leukaemia and is the most common leukaemia type in children with Down syndrome (DS) under 4 years of age. AMKL is often preceded by a transient neonatal pre-leukaemic syndrome, transient myeloproliferative disorder (TMD). Although TMD often spontaneously resolves, 20-30% of these patients subsequently develop AMKL within the first 4 years of life. AIMS To perform a retrospective consecutive national audit of all documented cases of childhood TMD and AMKL-DS fro
Like
Comment
Share
